2026 NPPES data Hematology & Oncology Physician NPI 1932193521 MD
Verify on CMS →

HARVEY COOPER, MD

Hematology & Oncology Physician in WAYNE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
39
Medicare Part D claims · Hematology & Oncology Physician avg: 847
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

HARVEY COOPER, MD filed 39 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in WAYNE, New Jersey, prescribing 59% generic.

39
Part D claims, 2023
59%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

HARVEY COOPER, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

39 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

HARVEY COOPER, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about HARVEY COOPER, MD?

Quality data not reported

NPI registry status

Active

Issued 09/09/2005

NPI 1932193521

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

39 95% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in New Jersey

How Hematology & Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Hematology & Oncology Physician share within New Jersey

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

HARVEY COOPER, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 220 HAMBURG TPKE, WAYNE, NJ, 07470, with a listed phone of (973) 942-0040. NPI 1932193521 was issued on 09/09/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what COOPER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 39 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $8K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

220 HAMBURG TPKE
WAYNE, NJ 07470

Provider Details

NPI 1932193521
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 09/09/2005

Brand vs generic prescribing mix · Above average

HARVEY COOPER, MD — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 39 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

39
Total Claims
$8K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
75
Total Day Supply
2,166
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$8K
Generic Drug Cost
$407

Patient Demographics

Average Patient Age
88.0 years
Avg HCC Risk Score
2.51

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How HARVEY COOPER, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

HARVEY COOPER, MD's 39 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as COOPER.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is HARVEY COOPER, MD's specialty?
HARVEY COOPER, MD specializes in Hematology & Oncology Physician and practices in WAYNE, New Jersey. Credentials: MD.
How much does HARVEY COOPER, MD prescribe under Medicare Part D?
In 2023, HARVEY COOPER, MD wrote 39 Medicare Part D claims totaling $8K in drug costs for N/A beneficiaries.
Where is HARVEY COOPER, MD located?
HARVEY COOPER, MD is located at 220 HAMBURG TPKE, WAYNE, NJ, 07470. Phone: (973) 942-0040.
What is HARVEY COOPER, MD's NPI number?
HARVEY COOPER, MD's National Provider Identifier (NPI) is 1932193521, issued on 09/09/2005.
Does HARVEY COOPER, MD prescribe more brand-name or generic drugs?
HARVEY COOPER, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $8K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does HARVEY COOPER, MD prescribe most often?
Based on 2023 Medicare Part D data, HARVEY COOPER, MD's most frequently prescribed drugs include Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does HARVEY COOPER, MD accept Medicare?
HARVEY COOPER, MD appears in CMS Medicare data with 39 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify HARVEY COOPER, MD's credentials?
HARVEY COOPER, MD's NPI is 1932193521 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology